Dr. Wolf-Henning Walther becomes new CEO at Metrohm Germany

Change in the Executive Board from September 1, 2025

15-Aug-2025

from left to right: Frank Rückle, Dr. Wolf-Henning Walther, Michael Feige

Dr. Wolf-Henning Walther will take over as Managing Director of Metrohm Deutschland GmbH & Co. KG on September 1, 2025 and will form the Executive Board together with Michael Feige and Dr. Volker Frost. Frank Rückle, the current Managing Director, will take his well-deserved retirement on September 1, 2025.

After more than 40 successful years at Metrohm Germany, including almost 13 years on the Executive Board, Frank Rückle will be taking his well-deserved retirement on September 1, 2025. With his dedication, professional expertise and commitment to customers and employees, he has played a key role in shaping the company. We would like to thank him warmly for his many years of successful work and for the many impulses that Metrohm Germany has experienced during this time.

At the same time, Dr. Wolf-Henning Walther will become the new Managing Director of Metrohm Germany as of September 1. He not only brings with him extensive experience in the laboratory sector and fresh impetus, but also a long-standing personal connection to Metrohm. In his previous position, he worked on numerous exciting projects with some of his current colleagues. He not only got to know and appreciate the technical excellence, but also the values practiced at Metrohm.

"Even during my chemistry studies, I was very impressed by the uncompromising quality and robustness of the products - Made in Switzerland. I am now all the more looking forward to actively shaping the next chapters of this success story together with a great team," explains Dr. Wolf-Henning Walther, CEO, Managing Director at Metrohm Germany from September 1.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department business & finance

Most read news

More news from our other portals

Last viewed contents

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Pioneers of epigenetics receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2026 - The prizewinners' discovery shook the foundations of classical genetics and opened the door to the vast field of modern epigenetics

Pioneers of epigenetics receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2026 - The prizewinners' discovery shook the foundations of classical genetics and opened the door to the vast field of modern epigenetics

Melina Schuh honored with Science Breakthrough 2025 - “It has always been my dream to make the entire ovulation process visible”

Melina Schuh honored with Science Breakthrough 2025 - “It has always been my dream to make the entire ovulation process visible”

Kai Beckmann to Succeed Belén Garijo as Chair of the Executive Board and CEO of Merck as of May 2026

Kai Beckmann to Succeed Belén Garijo as Chair of the Executive Board and CEO of Merck as of May 2026

Change of managing directors at 5-HT Chemistry & Health - Innovation partner for companies in the chemical, pharmaceutical, and healthcare industries under new management

Change of managing directors at 5-HT Chemistry & Health - Innovation partner for companies in the chemical, pharmaceutical, and healthcare industries under new management

Boehringer Ingelheim Pharma GmbH & Co. KG - Ingelheim am Rhein, Germany

Boehringer Ingelheim Pharma GmbH & Co. KG - Ingelheim am Rhein, Germany

Herz- und Diabeteszentrum Nordrhein-Westfalen (Universitätsklinik der Ruhr-Universität Bochum) - Bad Oeynhausen, Germany

Lead Discovery Center GmbH - Dortmund, Germany

Lead Discovery Center GmbH - Dortmund, Germany

Living heart muscle slices drive RNA research into heart failure - Researchers place living human heart tissue in a nutrient solution and use it to test new drugs and innovative approaches to combat heart failure

Living heart muscle slices drive RNA research into heart failure - Researchers place living human heart tissue in a nutrient solution and use it to test new drugs and innovative approaches to combat heart failure

Empa - St. Gallen, Switzerland

What Do Spiders Have in Common with Batteries? - Spider silk inspires new class of functional synthetic polymers: Conducting protein-based material could be used in fuel cells, batteries or act as sensor

What Do Spiders Have in Common with Batteries? - Spider silk inspires new class of functional synthetic polymers: Conducting protein-based material could be used in fuel cells, batteries or act as sensor

Sensors against superbugs - Dangerous increase in antimicrobial resistance: Detect resistant pathogens faster and start customized treatment in good time

Sensors against superbugs - Dangerous increase in antimicrobial resistance: Detect resistant pathogens faster and start customized treatment in good time